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To the Editor: In their recent article, Stevens et al.1 have
reported that factors other than glomerular filtration rate
(GFR) affect serum cystatin C (CysC) levels. Specifically,
they mentioned the impact of diabetes mellitus, which was
associated with 8.5% higher levels of CysC. However,
proteinuria was also associated with CysC and, as admitted
by the authors, diabetes and proteinuria were strongly
associated in their patient cohorts. Thus, their data did not
allow for determining the independent effects of diabetes
mellitus or proteinuria. We have previously reported GFR
data of a cohort of patients with normo-albuminuric diabetes
type I and age- and sex-matched controls.2 From this cohort,
we have selected 33 patients and 38 controls with matching
GFR (inulin clearance) and evaluated the relationship
between CysC and GFR.
At baseline, the mean GFR was 112±9ml/min per 1.73m2
and mean CysC was 0.68±0.1mg/l. In univariable regression
analysis, age (P¼ 0.016), gender (P¼ 0.001), serum albumin
(P¼ 0.001), and serum urea (P¼ 0.002) significantly influ-
enced the relationship of CysC with GFR. Diabetes was not a
predictor of this relationship (Figure 1). In multivariable
analysis age (P¼ 0.003), gender (P¼ 0.007), and serum urea
(P¼ 0.004) remained independent predictors.
In our cohort of type I diabetic patients with normal renal
function without proteinuria, we could not confirm the
influence of diabetes on the relationship between CysC
and GFR. The effect, as found by Stevens et al.,1 may be due
to the interaction with proteinuria, which was present in
the majority of their patients.
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To the Editor: Changing the chronic kidney disease (CKD)
staging system, as proposed by Winearls and Glassock,1 could
have a negative impact on prevention. One of the hardest
tasks faced by a nephrologist is breaking the news about
imminent dialysis to an unsuspecting patient. This gets ever
more painful if early signs of kidney disease, such as a mildly
depressed glomerular filtration rate (eGFR), were somehow
uncovered in the past but the patient was reassured without
further testing and sent home only to learn otherwise at a
later date. Bad as it seems, this is a recurrent experience for
any nephrologist. Therefore, we were concerned with this
proposition to revise the Kidney Disease Outcomes Quality
Initiative (KDOQI) staging system of CKD and eliminate the
current early stages of the system. Although we recognize that
a proportion of healthy individuals may be transitorily
mislabeled as CKD patients, we believe that it is better to
raise the possibility of incipient CKD and discard it afterward
than to miss diagnosis by not looking for it. The current
staging system of CKD has been very successful in bringing
worldwide uniformity to the nomenclature and has met the
goal of raising awareness within the renal and nonrenal
medical communities to new levels. Rather than a matter of
opinion, this is a ripe area for scientific inquiry. We challenge
the renal community, as would be the case with any new
classification system, to use tools of diagnostic statistics and
to determine the predictive values of KDOQI staging within
the different categories so that we can act and inform our
patients appropriately.
However, we do not disagree that a minor review of CKD
staging may be in order. The wide range of GFR that defines
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Figure 1 |Relationship between Cystatin C levels and
glomerular filtration rate (inulin clearance). Diabetes does not
influence this relationship.
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